Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 27 for AI

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Evaluation of the Total Kidney Volume AI Algorithm

    Rochester, MN

  2. Study of AI-Based Interpreter Tools in ICU Clinical Communication

    Rochester, MN

  3. AI-Based Voice Analysis for Hospitalized Acute Decompensated Heart Failure

    Rochester, MN

  4. A Study to Evaluate an AI Algorithm for Segmenting Adipose and Skeletal Muscle in Abdominal Imaging

    Rochester, MN

  5. Achieving Home Discharge for Institutionally-bound Patients with PROMs, AI, and the EHR – Calibration Study

    Rochester, MN

  6. AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction

    Rochester, MN

  7. Endometrial Cancer/Endometrial Atypical Hyperplasia with an AI-based Classifier in Transvaginal Ultrasound in Patients with Post-Menopausal Bleeding

    Rochester, MN, Jacksonville, FL, Scottsdale/Phoenix, AZ

  8. AI-Driven, FDG-PET Based Approach to Track Disease Progression and Evolution to Phenoconversion in Progranulin Mutation Carriers

    Rochester, MN

  9. Outcome Reflection for Immune Mediated Rejection by Utilizing AI in Cardiac Transplant During Early and Late Echocardiographic Analysis

    Rochester, MN

  10. Achieving Home Discharge for Institutionally-bound Patients Alzheimer's Disease and Alzheimer's Disease Related Dementias

    Rochester, MN

.

Mayo Clinic Footer